Commonwealth Equity Services’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,051
| Closed | -$4K | – | 4270 |
|
|
2025
Q1 | $4K | Hold |
12,051
| – | – | ﹤0.01% | 4166 |
|
|
2024
Q4 | $4K | Buy |
+12,051
| New | +$4K | ﹤0.01% | 4084 |
|
|
2022
Q3 | – | Sell |
-36,799
| Closed | -$14K | – | 3677 |
|
|
2022
Q2 | $14K | Hold |
36,799
| – | – | ﹤0.01% | 3603 |
|
|
2022
Q1 | $25K | Hold |
36,799
| – | – | ﹤0.01% | 3639 |
|
|
2021
Q4 | $24K | Buy |
36,799
+2,325
| +7% | +$1.52K | ﹤0.01% | 3590 |
|
|
2021
Q3 | $31K | Buy |
34,474
+7,482
| +28% | +$6.73K | ﹤0.01% | 3527 |
|
|
2021
Q2 | $32K | Buy |
26,992
+4,047
| +18% | +$4.8K | ﹤0.01% | 3483 |
|
|
2021
Q1 | $36K | Buy |
22,945
+7,530
| +49% | +$11.8K | ﹤0.01% | 3355 |
|
|
2020
Q4 | $32K | Buy |
+15,415
| New | +$32K | ﹤0.01% | 3158 |
|